ストックスクリーナーアプリを入手
0.7017
1.03%
-0.0073
アフターアワーズ：
.69
-0.0117
-1.67%
前日終値:
$0.709
開ける：
$0.7277
24時間の取引高:
498.69K
Relative Volume:
0.18
時価総額：
$4.63M
収益：
-
当期純損益:
$-10.31M
株価収益率:
-0.3011
EPS:
-2.3308
ネットキャッシュフロー:
$-6.32M
1週間 パフォーマンス:
+12.73%
1か月 パフォーマンス:
+11.38%
6か月 パフォーマンス:
-51.94%
1年 パフォーマンス:
-50.23%
1日の値動き範囲:
$0.6709
$0.735
1週間の範囲:
$0.66
$1.26
52週間の値動き範囲:
$0.4111
$2.68
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Compare GLMD vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
0.7017 | 4.68M | 0 | -10.31M | -6.32M | -2.3308 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-05-22 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | 開始されました | Craig Hallum | Buy |
| 2020-01-30 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-12-02 | 開始されました | Canaccord Genuity | Buy |
| 2018-12-12 | 開始されました | B. Riley FBR | Buy |
| 2018-08-02 | 繰り返されました | Maxim Group | Buy |
| 2018-07-13 | 開始されました | Stifel | Buy |
| 2018-07-12 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-06-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-03-15 | アップグレード | Maxim Group | Hold → Buy |
| 2018-02-14 | ダウングレード | Maxim Group | Buy → Hold |
| 2018-02-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-11-15 | 開始されました | ROTH Capital | Buy |
| 2017-08-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-07-31 | 繰り返されました | Maxim Group | Buy |
| 2016-08-01 | 繰り返されました | Maxim Group | Buy |
| 2016-07-06 | 再開されました | ROTH Capital | Buy |
| 2016-03-28 | 再開されました | H.C. Wainwright | Buy |
| 2015-06-23 | 開始されました | H.C. Wainwright | Buy |
| 2015-05-06 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
すべてを表示
Galmed Pharmaceuticals Ltd (GLMD) 最新ニュース
Galmed Pharmaceuticals Ltd. and Ramot At Tel Aviv University Enter Research Collaboration Agreement - marketscreener.com
Galmed partners with Tel Aviv University on brain cancer therapy By Investing.com - Investing.com Australia
Galmed Pharmaceuticals Teams with Tel Aviv University on Aramchol for Metastatic Brain Cancer - TipRanks
Galmed (NASDAQ: GLMD) and Tel Aviv University test Aramchol for brain cancer - Stock Titan
GLMD SEC FilingsGalmed Pharmaceu 10-K, 10-Q, 8-K Forms - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Galmed stock soars on brain-penetrating Aramchol formulation - MSN
Galmed Stock Soars On Brain-Penetrating Aramchol FormulationGalmed Pharmaceuticals (NASDAQ:GLMD) - Benzinga
Galmed Unveils Brain-Penetrant Aramchol Formulation, Expanding Flagship Drug Into CNS Diseases - TipRanks
Galmed Pharmaceuticals Maps Future with Aramchol Strategy - timothysykes.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol - ChartMill
[EFFECT] Galmed Pharmaceuticals Ltd. SEC Filing - Stock Titan
Going concern doubts and funding limits in Galmed (NASDAQ: GLMD) 2025 20-F - Stock Titan
MEDIA ADVISORY – Minister LeBlanc, Secretary of State Long and Parliamentary Secretary Myles to highlight investments supporting the Canadian Armed Forces following achievement of the NATO 2% defence spending target - Weekly Voice
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025 - ChartMill
Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Ideas Watch: Is Galmed Pharmaceuticals Ltd stock a good dividend stock2026 Update & Entry and Exit Point Strategies - baoquankhu1.vn
Portfolio Update: Can Galmed Pharmaceuticals Ltd grow without dilution2026 Recap & Safe Entry Point Alerts - baoquankhu1.vn
GLMD Stock Price, Quote & Chart | GALMED PHARMACEUTICALS LTD (NASDAQ:GLMD) - ChartMill
Sectors Review: Can Galmed Pharmaceuticals Ltd deliver consistent dividendsMarket Rally & Low Risk Growth Stock Ideas - baoquankhu1.vn
Galmed (GLMD) director David Sidransky reports initial share and option holdings - Stock Titan
Galmed (GLMD) CFO details Ordinary Share, option and RSU holdings - Stock Titan
[Form 3] Galmed Pharmaceuticals Ltd. In... - Stock Titan
Galmed Pharmaceuticals (NASDAQ: GLMD) CAO reports shares, options and RSUs - stocktitan.net
Galmed Pharmaceuticals Ltd. (GLMD) CSO details option holdings - Stock Titan
Galmed (GLMD) director Amir Poshinski details shares, RSUs and options - Stock Titan
Galmed Pharmaceuticals (GLMD) director Nir Shmuel details initial share and RSU holdings - Stock Titan
Aug Chart Watch: Will Galmed Pharmaceuticals Ltd. stock maintain dividend yieldShort Setup & Advanced Swing Trade Entry Plans - Naître et grandir
Smart Money: Is Galmed Pharmaceuticals Ltd stock a good dividend stockMarket Growth Review & Reliable Price Breakout Signals - baoquankhu1.vn
Galmed Pharmaceuticals Shares Edge Higher Following CEO’s Positive Update - MSN
Galmed Pharmaceuticals Shareholders Approve Proposal at Special Meeting - The Globe and Mail
Galmed Pharmaceuticals (NASDAQ: GLMD) shareholders back proposal at March 5 special meeting - Stock Titan
Galmed Pharmaceuticals Adjourns Special Shareholder Meeting for Lack of Quorum - TipRanks
Galmed Pharmaceuticals (GLMD) adjourns shareholder meeting and resets date - Stock Titan
GLMD.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
GLMD Should I Buy - Intellectia AI
Buyout Rumor: Will Galmed Pharmaceuticals Ltd benefit from government policyWeekly Trend Report & Fast Momentum Entry Tips - baoquankhu1.vn
GLMD PE Ratio & Valuation, Is GLMD Overvalued - Intellectia AI
Can Galmed Pharmaceuticals Ltd. ride the EV waveWeekly Trend Recap & Daily Profit Focused Screening - mfd.ru
Why Galmed Pharmaceuticals Ltd. (GPH) stock is a must watch tickerTrade Ideas & Comprehensive Market Scan Reports - mfd.ru
Dip Buying: Why Galmed Pharmaceuticals Ltd. (GPH) stock is a must watch tickerTrade Risk Assessment & Stepwise Swing Trade Plans - mfd.ru
Can Galmed Pharmaceuticals Ltd. deliver consistent dividends2025 Price Targets & Long-Term Growth Portfolio Plans - mfd.ru
What’s the RSI of Galmed Pharmaceuticals Ltd. stockTreasury Yields & Community Consensus Picks - mfd.ru
Galmed Pharmaceuticals schedules special shareholder meeting for March 4 - Investing.com Nigeria
Galmed Pharmaceuticals Sets March 4 Vote on Reverse Stock Split to Address Nasdaq Listing Deficiency - TipRanks
Galmed Pharmaceuticals (NASDAQ: GLMD) seeks shareholder approval for broad reverse split range - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Aug Summary: Will Galmed Pharmaceuticals Ltd benefit from government policyJuly 2025 Weekly Recap & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Galmed Pharmaceuticals Receives Nasdaq Minimum Bid Price Deficiency Notice - TipRanks
Galmed Pharmaceuticals receives Nasdaq minimum bid price notice - Investing.com
Galmed Pharmaceuticals Ltd (GLMD) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):